Wells Fargo’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,000
Closed -$35K 6690
2018
Q4
$35K Sell
3,000
-300
-9% -$4K ﹤0.01% 5637
2018
Q3
$67K Buy
3,300
+3,000
+1,000% +$61.6K ﹤0.01% 5508
2018
Q2
$5K Hold
300
﹤0.01% 6096
2018
Q1
$4K Buy
+300
New +$4.09K ﹤0.01% 6122

Other funds holding NITE

Wells Fargo's NITE Position: Q1 2019 in Review

Wells Fargo sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q1 2019, closing a stake of 3,000 shares — an estimated $35K sold.

Wells Fargo first reported a position in NITE in Q1 2018 and held it in 4 quarters. The position peaked at $67K in Q3 2018. 53 funds tracked by Wall St. Rank hold NITE as of Q1 2019.

  • Wells Fargo reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
  • Wells Fargo sold 3,000 Nightstar Therapeutics plc American Depositary Shares shares in Q1 2019, an estimated $35K.
  • Wells Fargo first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q1 2018 and held it in 4 quarters.
  • Wells Fargo's Nightstar Therapeutics plc American Depositary Shares position peaked at $67K in Q3 2018.
  • 53 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q1 2019.

Based on Wells Fargo's 13F filing for Q1 2019, filed 10 May 2019.